病毒清除市场规模、份额、成长分析、按类型、按应用、按最终用户、按方法、按地区 - 行业预测，2024-2031 年

2022年全球病毒清除市场规模为4929亿美元，从2023年的5722.6亿美元增长到2031年的18890.7亿美元，在预测期内（2024-2031年）预计复合年增长率为16.1。

由于在生产单株抗体、重组蛋白、糖蛋白和其他生技药品时迫切需要去除病毒颗粒和 TSE 病原体，病毒清除市场正在受到关注。这些产品面临多种污染物的风险，包括病毒、细菌和真菌，因此强有力的病毒安全措施至关重要。此外，对疫苗和生物治疗药物的需求不断增长，以及製药和生物技术领域投资的增加，也推动了市场的成长。由于製造商优先考虑病毒清除以确保产品的完整性和安全性，病毒清除过程的整体状况将在未来几年继续发生变化，强调对生物过程的合规性和有效性的关键关注，预计在未来几年将发生重大变化。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步

病毒清除市场规模：依方法及复合年增长率（2024-2031）

• 市场概况
• 病毒清除方法
  • 层析法
  • 滤
  • 沉淀
• 病毒灭活方法
  • PH值变化
  • 清洁剂（S/D）
  • 消毒
  • 干热
  • 其他的
• 病毒检测方法
  • 次世代定序（NGS）
  • 聚合酵素链锁反应(PCR)
  • 体内测定
  • 体外测定

病毒清除市场规模：依应用和复合年增长率（2024-2031）

• 市场概况
• 血液和血液製品
• 重组蛋白
• 细胞/基因疗法产品
• 疫苗

病毒清除市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 製药和生物技术产业
• 学术研究所
• CRO

病毒清除市场规模：依地区及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Charles River Laboratories
• Merck KGaA
• Texcell
• WuXi AppTec
• Sartorius AG
• Eurofins Scientific
• Vironova
• Syngene International
• Microbac Laboratories
• Creative Biolabs
• Nelson Labs
• SGS AG
• Lonza Group
• Bioscience Laboratories
• Labor Dr. Merk & Kollegen
• Gilead Sciences
• Poolbeg Pharma
• Incyte
• Genmab
• Biogen

结论和建议

Global Viral Clearance Market size was valued at USD 492.9 billion in 2022 and is poised to grow from USD 572.26 billion in 2023 to USD 1889.07 billion by 2031, growing at a CAGR of 16.1% during the forecast period (2024-2031).

The viral clearance market is gaining traction due to the essential need for eliminating viral particles and TSE agents during the production of monoclonal antibodies, recombinant proteins, glycoproteins, and other biologics. As these products face risks from various contaminants, including viruses, bacteria, and fungi, robust viral safety practices are becoming imperative. Furthermore, the increasing investments in the pharmaceutical and biotechnology sectors, alongside a rising demand for vaccines and biotherapeutic agents, are propelling growth in this market. As manufacturers prioritize viral clearance to ensure product integrity and safety, the overall landscape of viral clearance processes is expected to evolve significantly in the coming years, highlighting the critical focus on compliance and efficacy in bioprocessing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viral Clearance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viral Clearance Market Segmental Analysis

Global Viral Clearance Market is segmented by method, application, end-user and region. Based on method, the market is segmented into viral removal method, viral inactivation method and viral detection method. Based on application, the market is segmented into blood and blood products, recombinant proteins, cellular & gene therapy products and vaccines. Based on end-user, the market is segmented into pharmaceutical and biotech industry, academic research institutes and cros. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viral Clearance Market

The global viral clearance market is primarily driven by the increasing demand for biologics and vaccines, which significantly enhances market growth. Regulatory agencies place a high priority on ensuring viral safety, requiring comprehensive assessments and high-quality data for Investigational New Drug (IND) and Biologics License Application (BLA) approvals. This necessitates expertise in relevant processes and regulatory compliance, which not only facilitates strategic planning but also leads to potential savings in time, resources, and finances. Moreover, the rising prevalence of chronic viral infections and the urgent need for effective treatment options, coupled with increased investments in the life sciences sector and the development of innovative therapies, further fuel market expansion.

Restraints in the Global Viral Clearance Market

The Global Viral Clearance market faces several restraints that hinder its growth, notably the significant expenses and a shortage of skilled professionals in the field. The advanced technologies required for viral clearance studies come with high costs, which can deter investment and development. Additionally, the overall operational and procedural expenses related to viral safety add to these financial burdens, further constraining the market. The increasing demand for expertise combined with this skill gap only exacerbates these challenges, leading to higher costs and ultimately limiting the market's potential for growth and expansion in the evolving landscape of viral safety solutions.

Market Trends of the Global Viral Clearance Market

The Global Viral Clearance market is experiencing significant growth driven by an escalating demand for generics and biosimilars. As healthcare systems globally strive for cost-effective treatment options for chronic diseases, there is heightened investment in recombinant non-glycosylated proteins, which serve as a cornerstone for developing biosimilars. This trend is fueled by advancements in technology that enhance viral clearance processes, ensuring safety and efficacy. Furthermore, regulatory pressures and the increasing prevalence of chronic health conditions propel the market forward, making efficient viral clearance methodologies crucial for pharmaceutical and biopharmaceutical companies. Overall, these dynamics are shaping a robust and evolving landscape in the viral clearance sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Viral Clearance Market Size by Method & CAGR (2024-2031)

• Market Overview
• Viral Removal Method
  • Chromatography
  • Filtration
  • Precipitation
• Viral Inactivation Method
  • Ph Modification
  • Solvent Detergent (S/D)
  • Pasteurization
  • Dry Heat
  • Others
• Viral Detection Method
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • In Vivo Assay
  • In Vitro Assay

Global Viral Clearance Market Size by Application & CAGR (2024-2031)

• Market Overview
• Blood and Blood Products
• Recombinant Proteins
• Cellular & Gene Therapy Products
• Vaccines

Global Viral Clearance Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and Biotech Industry
• Academic Research Institutes
• CROs

Global Viral Clearance Market Size & CAGR (2024-2031)

• North America (Method, Application, End-User)
  • USA
  • Canada
• Europe (Method, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Texcell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vironova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microbac Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelson Labs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioscience Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labor Dr. Merk & Kollegen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poolbeg Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incyte
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genmab
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations